A minimally invasive method of testing for biomarkers of cancer and other diseases, the liquid biopsy can sidestep costly and stressful surgical procedures. All that you require are blood samples and sensitive and specific solutions to detect and analyze circulating cell-free DNA (cfDNA), exosomes and circulating tumor cells (CTCs).
QIAGEN offers a complete, efficient and streamlined workflow to empower your liquid biopsy research. From collection through analysis, our solutions help gain deep insight into the cfDNA, CTCs and exosomes in your samples, putting you well on your way to valuable biomarker discovery.
- Collect and stabilize samples in tubes made with a unique, non-crosslinking material designed for sensitive cfDNA
- Get the most out of your samples with state-of-the-art cfDNA, CTC and exosome isolation technologies
- Discover DNA mutations and RNA biomarkers with advanced next-generation sequencing and real-time qPCR solutions
- Gain valuable insight with powerful and dedicated bioinformatics solutions
When exosomes talk, cells listen
A transforming profession
Bringing closure to families
Fighting the unknown